Skip to content

Enhanced Consent for Symptom Provocation Research

Risks and Outcomes of Enhanced Consent in Symptom-provocation Research

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01809899
Enrollment
12
Registered
2013-03-13
Start date
2009-04-30
Completion date
2014-08-31
Last updated
2018-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma

Keywords

Trauma, Abuse, Domestic Violence, Rape, Assault, MRI

Brief summary

The overall goal of the proposed study is to insure the protection and safety of human subjects who have been previously exposed to interpersonal traumatic events and who are participants in symptom provocation research. The investigators intend to examine trauma history, cognitive, interpersonal, and genetic predictors of participants' unfavorable reaction to participation in research involving trauma-related script-driven imagery (SDI). The design includes comparing participants in a consent as usual group to participants in an enhanced consent group to see which minimizes unfavorable effects of participating in a research provocation study. In addition, the two different consent groups will be assessed for their effects on psychobiological and neurobiological stress response. Furthermore, the investigators will examine the relationship between the psychobiological responses and neural mechanism during SDI, and unfavorable reactions to participation in symptom provocation research.

Detailed description

The overall goal of the proposed study is to insure the protection and safety of human subjects who have been previously exposed to interpersonal traumatic events and who are participants in symptom provocation research. The investigators intend to examine trauma history, cognitive, interpersonal, and genetic predictors of participants' unfavorable reaction to participation in research involving trauma-related script-driven imagery (SDI). The design includes comparing participants with and without Posttraumatic Stress Disorder (PTSD) in a consent as usual group to participants in an enhanced consent group to see which group minimizes unfavorable effects of participating in a research provocation study. In addition, the two different consent groups will be assessed for their effects on psychobiological and neurobiological stress response. Furthermore, the investigators will examine the relationship between the psychobiological responses and neural mechanism during SDI, and unfavorable reactions to participation in symptom provocation research.

Interventions

Enhanced consent entails a more detailed consent procedure

BEHAVIORALConsent as Usual

Routine informed consent procedures

Sponsors

Georgetown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* nonsmoker * female * between 18-55 * experienced trauma * willing to have a brain scan * provide consent

Exclusion criteria

* alcohol abuse or dependence * bipolar disorder * suicidal intent * metal in the body or anything else that would interfere with an MRI * claustrophobia or inability to lie still for 45 minutes * receiving current counseling * on certain antidepressants, benzodiazepines, or other psychotropic medication * pregnant or nursing

Design outcomes

Primary

MeasureTime frameDescription
Blood Oxygen-Level Dependent (BOLD) SignalBaselineFunctional Magnetic Resonance Imaging (fMRI). We were examining differences in Blood Oxygen-Level Dependent (BOLD) signal indicating reaction to a stress-provocation paradigm between the Enhanced Consent and Consent as Usual conditions.

Secondary

MeasureTime frameDescription
Heart RateBaselineHeart rate was measured while in the scanner as a secondary psychobiological outcome to be considered in tandem with the BOLD signals from the scanner.

Participant flow

Recruitment details

12 participants were recruited, but we were unsuccessful in recruiting sufficient number of non-PTSD, but trauma exposed patients.

Participants by arm

ArmCount
Enhanced Consent Procedure
Participants in this group will receive an enhanced consent that will be an hour longer than usual. Consent procedure: Enhanced consent entails a more detailed consent procedure than is routine.
8
Consent as Usual Procedure
Participants in this group will receive a normal consent procedure to the study
4
Total12

Baseline characteristics

CharacteristicEnhanced Consent ProcedureConsent as Usual ProcedureTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
8 Participants4 Participants12 Participants
Region of Enrollment
United States
8 participants4 participants12 participants
Sex: Female, Male
Female
8 Participants4 Participants12 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 80 / 4
serious
Total, serious adverse events
0 / 80 / 4

Outcome results

Primary

Blood Oxygen-Level Dependent (BOLD) Signal

Functional Magnetic Resonance Imaging (fMRI). We were examining differences in Blood Oxygen-Level Dependent (BOLD) signal indicating reaction to a stress-provocation paradigm between the Enhanced Consent and Consent as Usual conditions.

Time frame: Baseline

Population: No analyses were conducted due to an error in the scanner that resulted in no usable neuroimaging or physiological data. This includes the BOLD signal as well as the heart rate data and all other data collected while in the scanner.

Secondary

Heart Rate

Heart rate was measured while in the scanner as a secondary psychobiological outcome to be considered in tandem with the BOLD signals from the scanner.

Time frame: Baseline

Population: No analyses were conducted due to an error in the scanner that resulted in no usable neuroimaging or physiological data. This includes the BOLD signal as well as the heart rate data and all other data collected while in the scanner.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026